Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits ...

Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small ...

Reflecting on 20 years of experience working as a scientist in Big Pharma and biotech, Louise Modis, Ph.D., CSO at Amphista ...

The Biden administration, through policy and leadership appointments, raised the level of government scrutiny over ...

Cell therapy has emerged as a transformative field, offering hope for patients with various diseases. However, as these therapies become increasingly complex, it is essential to address the challenges ...

At Abzena, efficiency forms the foundation of our drug development philosophy. We are dedicated to employing strategies that optimize process robustness, accelerate timelines, and uphold the highest ...